FDA Inspection 1051026 — Clinical Laboratories Of Hawaii, LLP
The FDA completed an inspection of Clinical Laboratories Of Hawaii, LLP on Apr 18, 2018 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 18, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Honolulu, HI (United States)
Additional Details
Clinical BA/BE